. 2022 May 2;23(9):5058. doi: 10.3390/ijms23095058

Table 1.

Possible CSC phenotypes of breast cancer according to the literature data.

Phenotype	Sources of Samples	Source
ABCG2⁺	Cell line HCC1937	[49]
ANTXR1⁺	Mouse mammary metastatic tumor, cell line TMD231	[50]
CD29⁺	Cell line MCF-7	[51]
CD61⁺	Mouse mammary tumor MMTV-Wnt-1	[52]
CD133⁺	Primary human breast tumor; cell lines MDA-MB-231, MCF-7, ZR-75	[53,54]
CXCR4⁺	Metastatic breast cancer; cell line MCF-7; mouse cell lines 4T1, 4T07, 168Farn, 67NR	[55]
PROCR⁺	Cell line MDA-MB-361; adipose tissue of the mammary gland of mice with MDA-MB-231	[56]
CD24⁺CD29⁺	Primary breast cancer BRCA1 mouse; mouse mammary tumor tissue MMTV-WNT1	[57]
CD24⁺CD49f⁺	BRCA1 mouse primary breast tumor	[58]
CD44⁺CD24^−/low	Primary human breast tumor; cell lines MCF-7, BT-549, MDA-MB-231, MDA-MB-361, MDA-MB-468, T47D, ZR75, SK-BR-3, HCC1937	[44]
CD49f^hiCD61^hi	Transgenic mouse model HER2/neu	[59]
CD133⁺ALDH1⁺	Invasive ductal breast tumor	[60]
CD44⁺CD24^−/lowABCG2⁺	MDA-MB-231 and MCF-7 cell lines	[61]
CD44⁺CD24^−/^lowALDH1⁺	Invasive ductal human breast cancer; cell lines MDA-MB-231, MDA-MB-453, MDA-MB-468, SUM149, SUM159, SK-BR-3, ZR-75, C 1954	[46,62]
CD44⁺CD24^−/^lowEpCAM⁺	Cell lines MCF-7, MDA-MB-231, SUM149 и SUM159	[42]
CD44⁺CD24^−/^lowSSEA-3⁺	MCF-7 and MDA-MB-231 cell lines	[63]
CD44⁺CD49f⁺CD133/2⁺	Primary ER–human breast tumor	[64]
CD44⁺CD133⁺ALDH1^+/^hi	Cell line MDA-MB-468	[65]
CD133^hiCXCR4^hiALDH1^hi	Invasive ductal human breast cancer	[66]
EpCAM⁺CD49f⁺	Aberrant human progenitor cells from BRCA1-mutant breast tissue	[67]
EpCAM^hiPROCR^hiSSEA-3⁺	MCF-7 and MDA-MB-231 cell lines	[63]
GD2⁺GD3⁺GD3S^hi	Cell lines MDA-MB-231 and MDA-MB-468	[68]